AQR Capital Management Portfolio holdings
AUM
$121B
1-Year Return
23.38%
This Quarter Return
+10.91%
1 Year Return
+23.38%
3 Year Return
+85.44%
5 Year Return
+156.19%
10 Year Return
+370.97%
AUM
$43.9B
AUM Growth
+$2.87B
(+7%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-2.45%
Top 10 Holdings %
Top 10 Hldgs %
13.25%
Holding
2,343
New
170
Increased
997
Reduced
1,015
Closed
151
Top Buys
| 1 |
Verizon
VZ
|
$108M |
| 2 |
Humana
HUM
|
$108M |
| 3 |
AT&T
T
|
$105M |
| 4 |
Kroger
KR
|
$94.3M |
| 5 |
3M
MMM
|
$90.8M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$149M |
| 2 |
JPMorgan Chase
JPM
|
$108M |
| 3 |
Merck
MRK
|
$90.2M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$86.7M |
| 5 |
Apple
AAPL
|
$76.8M |
Sector Composition
| 1 | Technology | 19.59% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 11.85% |
| 4 | Industrials | 11.38% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Seagate
STX
$40B
| $250K | ﹤0.01% |
4,762
-56,301
| -92% | -$2.96M |
|
2027
Enterprise Financial Services Corp
EFSC
$2.24B
| $250K | ﹤0.01% |
+5,101
| New | +$250K |
|
2028
Pennant Group
PNTG
$840M
| $246K | ﹤0.01% |
+22,386
| New | +$246K |
|
2029
Frontier Group Holdings
ULCC
$1.18B
| $244K | ﹤0.01% |
+23,754
| New | +$244K |
|
2030
BayCom
BCML
$327M
| $241K | ﹤0.01% |
12,708
-15,399
| -55% | -$292K |
|
2031
Arrowhead Research
ARWR
$4.02B
| $241K | ﹤0.01% |
6,024
-16,928
| -74% | -$677K |
|
2032
Interactive Brokers
IBKR
$26.8B
| $240K | ﹤0.01% |
+13,248
| New | +$240K |
|
2033
Esquire Financial Holdings
ESQ
$828M
| $239K | ﹤0.01% |
5,532
+204
| +4% | +$8.83K |
|
2034
CoreCivic
CXW
$2.11B
| $239K | ﹤0.01% |
20,652
+6,893
| +50% | +$79.7K |
|
2035
Artisan Partners
APAM
$3.26B
| $238K | ﹤0.01% |
8,013
-5,339
| -40% | -$159K |
|
2036
KBR
KBR
$6.4B
| $238K | ﹤0.01% |
4,570
-420
| -8% | -$21.8K |
|
2037
SSR Mining
SSRM
$4.28B
| $237K | ﹤0.01% |
+15,137
| New | +$237K |
|
2038
Liquidia Corp
LQDA
$2.48B
| $236K | ﹤0.01% |
37,041
-4,414
| -11% | -$28.1K |
|
2039
Anavex Life Sciences
AVXL
$807M
| $235K | ﹤0.01% |
25,378
-393
| -2% | -$3.64K |
|
2040
Farmers & Merchants Bancorp
FMAO
$359M
| $235K | ﹤0.01% |
8,628
+201
| +2% | +$5.46K |
|
2041
Uranium Energy
UEC
$4.96B
| $234K | ﹤0.01% |
60,369
+224
| +0.4% | +$869 |
|
2042
Brady Corp
BRC
$3.86B
| $234K | ﹤0.01% |
+4,960
| New | +$234K |
|
2043
Dimensional US Core Equity 2 ETF
DFAC
$37.3B
| $231K | ﹤0.01% |
+9,513
| New | +$231K |
|
2044
UFP Technologies
UFPT
$1.6B
| $231K | ﹤0.01% |
+1,957
| New | +$231K |
|
2045
Frontline
FRO
$4.93B
| $229K | ﹤0.01% |
18,892
-8,621
| -31% | -$105K |
|
2046
Cogent Communications
CCOI
$1.81B
| $229K | ﹤0.01% |
+4,015
| New | +$229K |
|
|
BKI
2047
DELISTED
Black Knight, Inc. Common Stock
BKI
| $228K | ﹤0.01% |
3,739
+239
| +7% | +$14.6K |
|
2048
The GEO Group
GEO
$2.92B
| $227K | ﹤0.01% |
20,736
+7,003
| +51% | +$76.7K |
|
2049
Collegium Pharmaceutical
COLL
$1.21B
| $227K | ﹤0.01% |
+9,773
| New | +$227K |
|
2050
HealthEquity
HQY
$7.88B
| $226K | ﹤0.01% |
+3,710
| New | +$226K |
|